Overview Java backend roles in 2026 demand strong fundamentals plus expertise in modern frameworks like Spring Boot and ...
The NAACP sued Elon Musk’s xAI Tuesday, alleging the company’s efforts to power its data centers in Tennessee and Mississippi are creating a health risk for local residents. Musk’s artificial ...
Friday's inflation report was a positive for U.S. stocks, but the data didn't move the needle enough to justify another Federal Reserve interest-rate cut in the months ahead. That might explain the ...
A Rockford Police Department general order incorrectly states the city does not own data from its license plate readers. Police Chief Carla Redd said the order is mistaken and will be corrected.
Abstract: False data injection (FDI) attacks can mislead the system operator to conduct incorrect dispatch decisions, causing cyber-induced physical line overloads. However, traditional false data is ...
A publicly accessible Amazon-hosted storage server allowed anyone with a web browser to access potentially hundreds of thousands of people’s personal data without needing a password. This included ...
Maine is poised to freeze large data-center construction, which would make it the first state to enact such a measure as communities across the U.S. grapple with fallout from the boom in artificial ...
Four-fifths of King Diamond's classic late-'80s lineup have reunited as Lex Legion, and they're wasting no time proving the chemistry is still very much alive. For Patino, the project is more than ...
NEW YORK, March 30, 2026 /PRNewswire/ -- If you're looking for affordable market data subscriptions, discounted trading tools, or a way to access real-time stock, forex, and index data without paying ...
For decades, astronomers have been puzzled by strange “zebra stripe” patterns in radio waves from the Crab Pulsar — bright bands separated by complete darkness. Now, new research suggests the answer ...
LEO Pharma A/S, a global leader in medical dermatology, today announced new long-term results from EFFISAYIL® ON, an ongoing five-year open-label extension study of the pivotal EFFISAYIL 1 trial and ...